Vorasidenib- A Paradigm Shift in IDH1- or IDH2-Mutant Low-Grade Glioma Treatment.

Authors :: Malik H
Hudaib M
Rehman A
Source :: JPMA. The Journal of the Pakistan Medical Association [J Pak Med Assoc] 2024 Oct; Vol. 74 (10), pp. 1912-1913.
Publication Year :: 2024

Subjects :: Humans
Mutation
Antineoplastic Agents therapeutic use
Pyridines therapeutic use
Triazines therapeutic use
Isocitrate Dehydrogenase genetics
Glioma drug therapy
Glioma genetics
Brain Neoplasms drug therapy
Brain Neoplasms genetics

Full Text Access

Tools